AT331966B - Verfahren zur herstellung eines mittels gegen hohen blutdruck - Google Patents

Verfahren zur herstellung eines mittels gegen hohen blutdruck

Info

Publication number
AT331966B
AT331966B AT195873A AT195873A AT331966B AT 331966 B AT331966 B AT 331966B AT 195873 A AT195873 A AT 195873A AT 195873 A AT195873 A AT 195873A AT 331966 B AT331966 B AT 331966B
Authority
AT
Austria
Prior art keywords
producing
blood pressure
high blood
against high
agent against
Prior art date
Application number
AT195873A
Other languages
English (en)
Other versions
ATA195873A (de
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ATA195873A publication Critical patent/ATA195873A/de
Application granted granted Critical
Publication of AT331966B publication Critical patent/AT331966B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT195873A 1972-03-06 1973-03-06 Verfahren zur herstellung eines mittels gegen hohen blutdruck AT331966B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00232294A US3833727A (en) 1972-03-06 1972-03-06 Hydralazine and beta-adrenergic blocking agent compositions for treating hypertension

Publications (2)

Publication Number Publication Date
ATA195873A ATA195873A (de) 1975-12-15
AT331966B true AT331966B (de) 1976-09-10

Family

ID=22872572

Family Applications (1)

Application Number Title Priority Date Filing Date
AT195873A AT331966B (de) 1972-03-06 1973-03-06 Verfahren zur herstellung eines mittels gegen hohen blutdruck

Country Status (19)

Country Link
US (1) US3833727A (de)
AT (1) AT331966B (de)
BE (1) BE796288A (de)
CA (1) CA1015662A (de)
CY (1) CY951A (de)
DD (1) DD103559A5 (de)
FR (1) FR2181786B1 (de)
GB (1) GB1385648A (de)
HK (1) HK23378A (de)
HU (1) HU165714B (de)
IE (1) IE37326B1 (de)
IL (1) IL41610A (de)
KE (1) KE2839A (de)
LU (1) LU67144A1 (de)
MY (1) MY7800295A (de)
NL (1) NL176746C (de)
PH (1) PH18901A (de)
SE (1) SE400472B (de)
ZA (1) ZA731505B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001421A (en) * 1971-10-27 1977-01-04 Syntex (U.S.A.) Inc. Thiazole cardiovascular agents
NZ196227A (en) * 1980-02-19 1984-09-28 Merck & Co Inc 1,2,5-thiadiazole derivative and ophthalmic compositions
US4521414A (en) * 1981-06-18 1985-06-04 The Texas A&M University System Ophthalmic compositions and their use for treating elevated intraocular pressure and glaucoma
US20110092507A1 (en) * 2009-10-20 2011-04-21 Chin-Tsai Fan Process for preparing R-(+)-3-morpholino-4-(3- tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole

Also Published As

Publication number Publication date
DE2310836B2 (de) 1976-11-04
HU165714B (de) 1974-10-28
BE796288A (fr) 1973-09-05
KE2839A (en) 1978-05-26
IL41610A (en) 1975-08-31
ATA195873A (de) 1975-12-15
HK23378A (en) 1978-05-12
IL41610A0 (en) 1973-04-30
MY7800295A (en) 1978-12-31
CY951A (en) 1978-12-22
NL176746C (nl) 1985-06-03
US3833727A (en) 1974-09-03
LU67144A1 (de) 1973-09-06
IE37326B1 (en) 1977-06-22
DD103559A5 (de) 1974-02-05
SE400472B (sv) 1978-04-03
GB1385648A (en) 1975-02-26
FR2181786B1 (de) 1976-05-14
NL7302728A (de) 1973-09-10
DE2310836A1 (de) 1973-09-20
IE37326L (en) 1973-09-06
AU5266273A (en) 1974-08-29
CA1015662A (en) 1977-08-16
FR2181786A1 (de) 1973-12-07
NL176746B (nl) 1985-01-02
PH18901A (en) 1985-10-30
ZA731505B (en) 1974-10-30

Similar Documents

Publication Publication Date Title
AT339039B (de) Verfahren zur herstellung eines olefinpolymeren
AT322400B (de) Verfahren zur herstellung eines schleifkoerpers
AT323412B (de) Verfahren zur herstellung eines ionenpolymeren
AT338981B (de) Verfahren zur herstellung eines diagnostischen mittels zur kontrolle der gerinnungsfahigkeit des blutes
ATA287570A (de) Verfahren zur herstellung eines rohrformigen hohlkorpers
CH550032A (de) Verfahren zur herstellung eines rohres mittels eines metallbandes.
AT325038B (de) Verfahren zur herstellung eines optisch aktiven lactons
AT347577B (de) Verfahren zur herstellung eines antiviralen mittels
AT331966B (de) Verfahren zur herstellung eines mittels gegen hohen blutdruck
AT335616B (de) Verfahren zur herstellung eines mittels fur die spinalanasthesie
CH543878A (de) Verfahren zur Herstellung eines diagnostischen Mittels für medizinische Zwecke
AT331105B (de) Verfahren zur herstellung eines obersartigen konzentrats
AT358737B (de) Verfahren zur herstellung eines antihaemophilen mittels
AT335240B (de) Verfahren zur herstellung eines verstarkten druckschlauches
CH552377A (de) Verfahren zur herstellung eines diagnostischen mittels fuer medizinische zwecke.
AT317435B (de) Verfahren zur Herstellung eines antiseborrhoisch wirksamen Mittels
AT305124B (de) Verfahren zur Herstellung eines Mittels zur Aromatisierung
AT332539B (de) Verfahren zur herstellung eines immunisierungsmittels
AT330962B (de) Verfahren zur herstellung eines praparates zur nasalen applikation
AT314328B (de) Verfahren zur Herstellung eines flexiblen Zylinders
AT329743B (de) Verfahren zur herstellung eines praparates zur nasalen applikation
AT334725B (de) Verfahren zur herstellung eines eiersatzes
AT331024B (de) Verfahren zur herstellung eines elastomerlatex
AT283043B (de) Verfahren zur Herstellung eines Mittels zur Bekämpfung von Coccidiose
CH502300A (de) Verfahren zur Herstellung eines Aralkylaminoalkohols

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties